Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer
Authors:
- Mark GarzottoMGMark Garzotto
- Anne MyrthueAMAnne Myrthue
- Celestia S. HiganoCHCelestia S. Higano
- Tomasz M. BeerTBTomasz M. Beer
- 1 May 2006
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 24 (3) , 254-259
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413Journal of Clinical Oncology, 2003
- Three‐month neoadjuvant hormonal therapy before radical prostatectomy: a 7‐year follow‐up of a randomized controlled trialBJU International, 2002
- Preoperative neoadjuvant androgen withdrawal therapy in prostate cancer: the canadian experienceUrology, 2002
- Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trialThe Lancet, 2002
- RADICAL PROSTATECTOMY FOR PATHOLOGICAL GLEASON 8 OR GREATER PROSTATE CANCER: INFLUENCE OF CONCOMITANT PATHOLOGICAL VARIABLESJournal of Urology, 2002
- Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on radiation therapy oncology group clinical trialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999
- Statistical Modeling Using Preoperative Prognostic Variables in Predicting Extracapsular Extension and Progression after Radical Prostatectomy for Prostate CancerMilitary Medicine, 1998
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997